Skip to content

Clinical trials

Completed Central Nervous System Diseases trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Central Nervous System Diseases Status: Completed Country / region: France Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20091
20101
20111
20131
20161
20181
20191
20202
20212
20223
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
Assistance Publique - Hôpitaux de Paris2
Novartis2
Alkahest, Inc.1
BBB-Therapeutics B.V.1
Centre Hospitalier Universitaire de Nice1
Centre d'Investigation Clinique et Technologique 8051
Eli Lilly and Company1
Guerbet1
Inmune Bio, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Central Nervous System Diseases17
Brain Diseases10
Nervous System Diseases10
Neurodegenerative Diseases8
Parkinson Disease5
Movement Disorders4
Parkinsonian Disorders4
Alzheimer Disease3
Dementia2
Mental Disorders2

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.